Intracarotid arterial infusion with CDDP in combination with angiotensin Ii
Mitsuhata, N.; Hino, N.; Tagusagawa, Y.; Suga, K.; Nishigaki, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(12 Part 1): 2594-2597
1984
ISSN/ISBN: 0385-0684 PMID: 6439121 Document Number: 230455
Intracarotid CDDP infusion in combination with angiotensin II was performed in two patients with metastatic brain tumor, lung carcinoma (LC) and ovarian carcinoma (OC). The patient with OC received 40 mg/m2 CDDP while the other patient with LC was administered intra-arterially with 50 mg/m2 CDDP, 30 mg/m2 ADM and 2.5 mg/m2 MMC. 50% or greater reduction in the size of metastatic lesions was observed in both patients in whom no neurological toxicities developed. Intra-arterial infusion of CDDP either alone or in combination with ADM or MMC seems to present an aggressive approach in dealing with other metastatic neoplasms without increasing toxicity, especially if intra-arterial angiotensin II is infused concomitantly.